Companies: 10,795·Total market cap: $144.5T
Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

HOWLNASDAQHealthcare● Active
$0.38
$-0.01(-2.65%)
Market Cap$18559118
P/E Ratio
52W High$2.38
52W Low$0.37
Overview

Werewolf Therapeutics, Inc. (HOWL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · HOWL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.21howl eps ttm · howl earnings per shareEarnings history
PE Ratio (TTM)howl pe ratio ttm · howl price to earningsPE Ratio deep dive
Revenue (TTM)0.00howl revenue ttm · howl annual revenueFull revenue history
Dividend YieldNo Dividenddoes howl pay dividends · howl dividend yieldDividend history
Shares Outstanding46.0Mhowl shares outstanding · howl floatShares outstanding history
Next EarningsAug 13, 2026Est.howl earnings date · howl next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00▼ 100.00% YoY
202320242025
werewolf therapeutics, inc. revenue · howl revenue 2025
FY 2025Net Income-$60.8M▲ +13.75% YoY
202320242025
werewolf therapeutics, inc. net income · howl profit 2025
FY 2025EPS$-1.32▲ +19.02% YoY
202320242025
howl eps · werewolf therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$56.3MEPS: $-1.21View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy9 analystsis howl a buy · howl analyst rating
Strong Buy
0
Buy
9
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$1.00Low
$0.38Current
$1.00Avg Target161.85% upside
$1.00High
howl price target · howl 12 month forecast

Total: 9 · Buy rate: 100.0%

The HOWL analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing +161.85% upside from the current price of $0.38.

Stock Performance

Full History
1D-2.65%
1W-12.55%
1M-43.84%
3M-39.56%
YTD-39.72%
1Y-72.91%
5Y-96.78%

About Werewolf Therapeutics, Inc.

CEODaniel J. Hicklin
IPO DateApr 30, 2021
Employees46
CountryUS

Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the…

what is werewolf therapeutics, inc. · howl stock overview · werewolf therapeutics, inc. company profile · who is werewolf therapeutics, inc. ceo · howl NASDAQ · werewolf therapeutics, inc. headquarters · werewolf therapeutics, inc. business segments

About Stock Overview & Key Data

Werewolf Therapeutics, Inc. (HOWL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 30, 2021. As of the latest trading session, HOWL stock price is $0.38, with a market capitalization of $18.6M. The stock has returned -72.91% over the past 12 months and -39.72% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Werewolf Therapeutics, Inc. stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2025, Werewolf Therapeutics, Inc. reported revenue of — and net income of -$60.8M. For detailed data — including Werewolf Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Werewolf Therapeutics, Inc. (HOWL) stock price is $0.38. The stock is traded on NASDAQ under the ticker symbol HOWL. The 52-week range is $0.37 – $2.38.

HOWL stock priceHOWL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice